ASTELLAS PHARMA UNSP.ADR (YPHA) — Net Asset Momentum
ASTELLAS PHARMA UNSP.ADR (YPHA) recorded a net asset momentum of -5.2% as of March 2025, with net assets of €1.51 Trillion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check ASTELLAS PHARMA UNSP.ADR tangible net worth ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
ASTELLAS PHARMA UNSP.ADR Net Asset Momentum (2022–2025)
This chart tracks ASTELLAS PHARMA UNSP.ADR's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -5.2%, with net assets of €1.51 Trillion EUR as of March 2025. Read total liabilities of ASTELLAS PHARMA UNSP.ADR for a breakdown of total debt and financial obligations.
Annual Net Asset History for ASTELLAS PHARMA UNSP.ADR (2022–2025)
The table below shows the complete annual net asset history for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of ASTELLAS PHARMA UNSP.ADR.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €1.51 Trillion | €3.34 Trillion | €1.83 Trillion | ▼ -5.2% |
| 2024 | €1.60 Trillion | €3.57 Trillion | €1.97 Trillion | ▲ +5.8% |
| 2023 | €1.51 Trillion | €2.46 Trillion | €948.56 Billion | ▲ +3.3% |
| 2022 | €1.46 Trillion | €2.33 Trillion | €872.09 Billion | — |